Commitments and Contingencies (Details Narrative) - USD ($) |
3 Months Ended | 12 Months Ended | |||||||
|---|---|---|---|---|---|---|---|---|---|
Mar. 08, 2019 |
Jan. 14, 2019 |
Nov. 15, 2018 |
Sep. 29, 2014 |
Jan. 07, 2013 |
Mar. 31, 2019 |
Mar. 31, 2018 |
Dec. 31, 2018 |
Sep. 24, 2014 |
|
| Royalty expenses | $ 31,284 | $ 31,689 | |||||||
| ChubeWorkx [Member] | |||||||||
| Royalty expenses | 15,642 | ||||||||
| Thorofare Lease [Member] | |||||||||
| Operating lease with annual rentals including common area maintenance | 132,000 | ||||||||
| Lease agreement, extended term | 7 years | ||||||||
| Lease agreement, expiration date | Dec. 31, 2019 | ||||||||
| Rent expense | 41,365 | 42,218 | |||||||
| Pitman Lease [Member] | |||||||||
| Operating lease with annual rentals including common area maintenance | 40,839 | ||||||||
| Rent expense | $ 6,156 | $ 10,210 | $ 9,913 | ||||||
| Lease, term of agreement | 29 months | 60 months | |||||||
| Lease agreement, term description | The lease took effect on August 1, 2017 and runs through December 31, 2019. | ||||||||
| Security deposit | $ 4,950 | ||||||||
| Settlement Agreement [Member] | |||||||||
| Settlement agreed amount | $ 2,250,000 | ||||||||
| Insurance coverage amount | 500,000 | ||||||||
| Loss Contingency, Damages Sought, Value | $ 500,000 | ||||||||
| Settlement Agreement [Member] | Watts Action [Member] | |||||||||
| Payment of attorney' fees | $ 200,000 | ||||||||
| Settlement Agreement [Member] | ChubeWorkx [Member] | |||||||||
| Percentage of royalty received | 5.00% | ||||||||
| Percentage of royalty retain | 50.00% | ||||||||
| Due to related parties owned | $ 549,609 | ||||||||
| Settlement Agreement [Member] | ChubeWorkx [Member] | Royalty [Member] | |||||||||
| Royalty revenue | $ 5,000,000 | ||||||||
| Marketing Contract [Member] | |||||||||
| Allegations, description | On November 15, 2018, Typenex Medical LLC ("Typenex"), a telemarketing entity with whom the Company had entered into a marketing and commission agreement dated September 30, 2016 (the "Marketing Contract"), filed an arbitration against the Company before JAMS ADR (the "Arbitration"), and an arbiter was appointed to the Arbitration on December 14, 2018. In the Arbitration, Typenex has stated that it seeks "at least" $220,500 based on the allegation that the Marketing Contract entitles Typenex to a commission on sales of certain of the Company's heparin-related products in the period two years from the Marketing Contract's expiration | ||||||||
| Marketing Contract [Member] | Minimum [Member] | |||||||||
| Loss Contingency, Damages Sought, Value | $ 220,500 | ||||||||